Sigma-Aldrich Announces Service Provider for Whole Genome Amplification Technology
Sigma-Aldrich announced MOgene, LC as its first service provider of the GenomePlex® Whole Genome Amplification (WGA) technology. This follows a recent licensing agreement with Rubicon genomics, allowing Sigma to offer GenomePlex Whole Genome Amplification kits to service providers.
MOgene, LC is an Agilent certified services provider for microarray-based gene expression and Comparative Genomic Hybridization (CGH), currently offering high content, Agilent pre-printed, catalog microarrays for gene expression analysis. By expanding its service to include Whole Genome Amplification, MOgene is able to provide a complete solution to the customer's gene expression workflow.
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents

Smartphone lab finds coronavirus in saliva - Diagnosis of other infectious diseases possible
Affimed Appoints Dr. Wolfgang Fischer as Chief Operating Officer
S*BIO Announces US$5 Million Investment by Mitsui Ventures

Merck Expands Corporate Venture Fund M Ventures with a New Investment of € 600 Million - “Over the past decade, M Ventures has established itself globally as a leading partner to the biotech and tech venture ecosystems”

Fujifilm to Invest Over 200 Billion yen to Establish New Large-Scale Cell Culture Manufacturing Site for Biopharmaceuticals in the U.S.A. - End-to-End Single-Site Solution from Drug Substances to Fill-Finish & Packaging
Researchers discover that DNA naturally fluoresces
